Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biobucks
Biotech
Merck pens $300M-per-drug collab to find hidden tumor antigens
Merck & Co. has penned a $300 million biobucks-per-product deal to identify previously secret antigens for off-the-shelf cancer immunotherapies.
James Waldron
Feb 19, 2025 7:00am
Xeno's gastric-bypass pill alternative to be tested for C. diff
Jan 6, 2025 7:15am
Ipsen taps Biomunex's MAITs to treat solid tumors in $610M bet
Dec 3, 2024 6:00am
Acadia inks $582M biobucks pact for Danish biotech's neuro asset
Nov 26, 2024 5:00pm
GSK pays Flagship biotech $80M for preclinical neuro pact
Nov 12, 2024 6:30am
AbbVie pays $65M for options on EvolveImmune's T-cell engagers
Oct 31, 2024 10:00am